Roberta B. Ness et al. [9] J. W. Mouton, M. F. Peeters, J. H. van Rijssort-Vos, and R. P. Verkooyen, “Tubal factor pathology caused by Chlamydia trachomatis: the role of serology,” International Journal of STD & AIDS, vol. 13, supplement 2, pp. 26–29, 2002. [10] R. B. Ness, M. T. Goodman, C. Shen, and R. C. Brunham, “Serologic evidence of past infection with Chlamydia tra- chomatis, in relation to ovarian cancer,” Journal of Infectious Diseases, vol. 187, no. 7, pp. 1147–1152, 2003. [11] A. P. Gijsen, J. A. Land, V. J. Goossens, M. E. P. Slobbe, and C. A. Bruggeman, “Chlamydia antibody testing in screening for tubal factor subfertility: the signiﬁcance of IgG antibody decline over time,” Human Reproduction, vol. 17, no. 3, pp. 699–703, 2002. [12] R. B. Ness, D. E. Soper, H. E. Richter, et al., “Chlamydia antibodies, chlamydia heat shock protein, and adverse seque- lae after pelvic inﬂammatory disease: the PID Evaluation and Clinical Health (PEACH) Study,” Sexually Transmitted Diseases, vol. 35, no. 2, pp. 129–135, 2008. 5